| Metric | Q4 FY26 | Q3 FY26 | Q4 FY25 |
|---|---|---|---|
| Revenue from operations | 1.7 | 1.4 | 1.5 |
| Other income | 0.2 | 0.1 | 0.1 |
| Total income | 1.9 | 1.5 | 1.5 |
| Profit before exceptional items & tax | 0.2 | 0.1 | 0.1 |
| Profit before tax | 0.2 | 0.1 | 0.1 |
| Net profit | 0.2 | 0.1 | 0.2 |
| Operating margin | 10.5% | 6.7% | 6.7% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +0.00% |
|---|---|
| Net profit, quarter on quarter | +100.00% |
| Revenue, year on year | +13.30% |
BSE results filing, NSE: COLINZ. Figures extracted from the filing.
Colinz Laboratories Ltd: key numbers
- Share price
- ₹76.20
- Market cap
- ₹19.20 Cr
- Revenue (annual)
- ₹6.14 Cr
- Net profit (annual)
- ₹0.51 Cr
- P/E (TTM)
- 6.9×Sector 50.4×
- Promoter holding
- 50.60%-15.40% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Colinz Laboratories Ltd
All →Colinz Laboratories Annual General Meeting
Colinz Laboratories held its 40th Annual General Meeting on September 22, 2026, where shareholders considered financial statements and director appointments.
Colinz Laboratories Open Offer: ₹3.54 Cr
Colinz Laboratories Ltd issued a Post Offer Advertisement for an Open Offer. The offer closed with only 6 shares tendered out of a proposed 6,54,966 shares.
- Value
- ₹3.54 Cr
Colinz Laboratories Q1 FY27 Results: Net Profit ₹2.4 Cr, Up 2300.0% YoY
Colinz Laboratories Ltd reported revenue from operations of ₹1.2 Cr (-25.0% YoY) and net profit of ₹2.4 Cr (+2300.0% YoY) for Q1 FY27.
- Key figure
- Net profit ₹2.4 Cr · +2300.0% YoY